11-Oct-2024
Jefferies Sticks to Its Hold Rating for Baxter International (BAX)
TipRanks (Thu, 10-Oct 8:05 AM ET)
TipRanks (Thu, 10-Oct 5:31 AM ET)
Baxter issues updates on supply issues caused by Hurricane Helene
Seeking Alpha News (Wed, 9-Oct 10:47 AM ET)
Baxter International Addresses Hurricane Helene Production Impact
TipRanks (Wed, 9-Oct 9:49 AM ET)
Deutsche Bank Sticks to Their Hold Rating for Baxter International (BAX)
TipRanks (Tue, 8-Oct 9:05 AM ET)
Baxter Provides Update on North Cove, N.C., Facility and Hurricane Helene Relief Plans for Community
Business Wire (Sun, 29-Sep 4:00 PM ET)
Baxter Launches Next Generation of The Vest System for Airway Clearance
Business Wire (Thu, 26-Sep 7:30 AM ET)
Baxter Appoints Jeffrey A. Craig to Its Board
Business Wire (Mon, 9-Sep 9:00 AM ET)
Spectral Medical Provides August Tigris Trial Update
Globe Newswire (Tue, 3-Sep 7:30 AM ET)
Baxter to Present at 2024 Wells Fargo Healthcare Conference
Business Wire (Wed, 28-Aug 4:15 PM ET)
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's revenue comes from more digitally connected offerings like its smart beds and Voalte medical communications app. From its legacy operations, Baxter sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. It has signed an agreement to sell its kidney care segment by early 2025.
Baxter Intl trades on the NYSE stock market under the symbol BAX.
As of October 11, 2024, BAX stock price declined to $36.54 with 3,028,282 million shares trading.
BAX has a beta of 0.36, meaning it tends to be less sensitive to market movements. BAX has a correlation of 0.03 to the broad based SPY ETF.
BAX has a market cap of $18.64 billion. This is considered a Large Cap stock.
Last quarter Baxter Intl reported $4 billion in Revenue and $.68 earnings per share. This beat revenue expectation by $62 million and exceeded earnings estimates by $.02.
In the last 3 years, BAX traded as high as $89.70 and as low as $31.01.
The top ETF exchange traded funds that BAX belongs to (by Net Assets): VTI, VOO, VO, SPY, IVV.
BAX has underperformed the market in the last year with a price return of +15.1% while the SPY ETF gained +34.4%. However, in the short term, BAX had mixed performance relative to the market. It has outperformed in the last 3 months, returning +4.6% vs +4.5% return in SPY. But in the last 2 weeks, BAX shares have been beat by the market, returning -6.1% compared to an SPY return of +1.4%.
BAX support price is $36.31 and resistance is $37.75 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BAX shares will trade within this expected range on the day.